Elaine K. Perry

Active 1977–2019

90
Papers
29,680
Citations
79
h-index
90
i10-index

Citations

Citations per year for Elaine K. Perry1967: 1 citations1977: 2 citations1978: 2 citations1979: 5 citations1980: 25 citations1981: 43 citations1982: 53 citations1983: 94 citations1984: 92 citations1985: 136 citations1986: 158 citations1987: 123 citations1988: 124 citations1989: 75 citations1990: 110 citations1991: 75 citations1992: 83 citations1993: 66 citations1994: 98 citations1995: 73 citations1996: 98 citations1997: 120 citations1998: 150 citations1999: 166 citations2000: 269 citations2001: 250 citations2002: 277 citations2003: 337 citations2004: 303 citations2005: 297 citations2006: 322 citations2007: 314 citations2008: 309 citations2009: 325 citations2010: 278 citations2011: 304 citations2012: 253 citations2013: 233 citations2014: 242 citations2015: 188 citations2016: 231 citations2017: 230 citations2018: 206 citations2019: 540 citations2020: 442 citations2021: 405 citations2022: 298 citations2023: 224 citations2024: 309 citations2025: 134 citations2026: 3 citations1968–1976: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,696 citing papers, 25.1% of this breakdownUnited Kingdom: 1,422 citing papers, 13.3% of this breakdownItaly: 482 citing papers, 4.5% of this breakdownGermany: 463 citing papers, 4.3% of this breakdownJapan: 439 citing papers, 4.1% of this breakdownCanada: 432 citing papers, 4% of this breakdownFrance: 331 citing papers, 3.1% of this breakdownChina: 330 citing papers, 3.1% of this breakdownAustralia: 320 citing papers, 3% of this breakdownSweden: 319 citing papers, 3% of this breakdownSpain: 300 citing papers, 2.8% of this breakdownNetherlands: 294 citing papers, 2.7% of this breakdown
0%25.1%Other 27%

Fields

  • Medicine66.1%
  • Neuroscience16.8%
  • Biochemistry, Genetics and Molecular Biology10.1%
  • Agricultural and Biological Sciences2.5%
  • Psychology0.9%
  • Computer Science0.6%
  • Other3%

Topics

  • Alzheimer's disease research and treatments10.6%
  • Dementia and Cognitive Impairment Research8.7%
  • Parkinson's Disease Mechanisms and Treatments7.3%
  • Cholinesterase and Neurodegenerative Diseases6.5%
  • Neuroscience and Neuropharmacology Research3.5%
  • Nicotinic Acetylcholine Receptors Study3.2%
  • Other60.2%

Coauthors

All papers

Open in search
  1. Diagnosis and management of dementia with Lewy bodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenji Kosaka, V.M.Y. Lee, Andrew J. Lees, Irene Litvan, Elisabet Londos, Oscar L. López, Satoshi Minoshima, Y Mizuno, J. A. Molina, Elizabeta B. Mukaetova‐Ladinska, Florence Pasquier, R. H. Perry, Jörg B. Schulz, John Q. Trojanowski, Masahito Yamada - Neurology 2005 cited by 5,057

  2. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors

    Authors: , , , , , , , , , , , , , , - The Lancet Neurology 2008 cited by 1,231

  3. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Neurology 1996 cited by 3,973

  4. CHANGES IN BRAIN CHOLINESTERASES IN SENILE DEMENTIA OF ALZHEIMER TYPE

    Authors: , , , - Neuropathology and Applied Neurobiology 1978 cited by 555

  5. Role of phytochemicals as nutraceuticals for cognitive functions affected in ageing

    Authors: , , , - British Journal of Pharmacology 2019 cited by 98

  6. In-vitro Inhibition of Human Erythrocyte Acetylcholinesterase by Salvia lavandulaefolia Essential Oil and Constituent Terpenes

    Authors: , , , , - Journal of Pharmacy and Pharmacology 2000 cited by 452

  7. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

    Authors: , , , , , - BMJ 1978 cited by 2,049

  8. Medicinal Plants and Alzheimer's Disease: from Ethnobotany to Phytotherapy

    Authors: , , , , - Journal of Pharmacy and Pharmacology 1999 cited by 284

  9. Aromatherapy as a Safe and Effective Treatment for the Management of Agitation in Severe Dementia

    Authors: , , , - The Journal of Clinical Psychiatry 2002 cited by 389

  10. Stage-Specific Changes in Neurogenic and Glial Markers in Alzheimer’s Disease

    Authors: , , , , , , , , , , - Biological Psychiatry 2014 cited by 81

  11. Pathological changes in the nucleus of meynert in Alzheimer's and Parkinson's diseases

    Authors: , , , , , , - Journal of the Neurological Sciences 1983 cited by 459

  12. Cholinergic Activity in Autism: Abnormalities in the Cerebral Cortex and Basal Forebrain

    Authors: , , , , , , , , , , - American Journal of Psychiatry 2001 cited by 384

  13. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm)

    Authors: , , , , - Pharmacology Biochemistry and Behavior 2002 cited by 248

  14. Molecular Forms of Acetylcholinesterase and Butyrylcholinesterase in the Aged Human Central Nervous System

    Authors: , , , , - Journal of Neurochemistry 1986 cited by 202

  15. Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology

    Authors: , , , , , - Neurobiology of Disease 2012 cited by 172

  16. In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease

    Authors: , , , , , , , , , , - Journal of Pharmacy and Pharmacology 2001 cited by 160

  17. Neurotransmitter enzyme abnormalities in senile dementia

    Authors: , , , , - Journal of the Neurological Sciences 1977 cited by 722

  18. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution

    Authors: , , , , , , , , , , , - Brain 1999 cited by 334

  19. Coenzyme a-acetylating enzymes in Alzheimer's disease: Possible cholinergic ‘compartment’ of pyruvate dehydrogenase

    Authors: , , , , - Neuroscience Letters 1980 cited by 232

  20. Neuroleptic Sensitivity in Parkinson's Disease and Parkinsonian Dementias

    Authors: , , , , , , , - The Journal of Clinical Psychiatry 2005 cited by 221

  21. Modulation of Mood and Cognitive Performance Following Acute Administration of Single Doses of Melissa Officinalis (Lemon Balm) with Human CNS Nicotinic and Muscarinic Receptor-Binding Properties

    Authors: , , , , , , - Neuropsychopharmacology 2003 cited by 197

  22. Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases

    Authors: , , , , , , , , - Journal of the Neurological Sciences 1991 cited by 99

  23. THE CHOLINERGIC HYPOTHESIS—TEN YEARS ON

    Authors: - British Medical Bulletin 1986 cited by 563

  24. An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers

    Authors: , , , , , , - Psychopharmacology 2008 cited by 161